Anthracyclinone derivatives and their use in amyloidosis
US6096888A · kind A · utility
7Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 1999 |
| Grant date | Aug 1, 2000 |
| Priority date | — |
| Expiry date | Sep 14, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4, and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their preparation and pharmaceutical composition containing them are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.